8WQ-34250-06442
1 vaccination
1 coded response
10 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 277 / NC
- Registered
- 2021-07-13
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-13
Registered in v-safe
-
2021-07-13
Dose 1 — Pfizer-BioNTech
-
2021-07-13
Survey response — day 0, dose 1MedDRA: Injection site pain, Reaction to previous exposure to any vaccine — Feeling: GoodFree text: Minor pain at injection site, but at normal level I experience with any vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-14
- 2021-07-15
- 2021-07-16
- 2021-07-17
- 2021-07-18
-
2021-07-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2021-07-20
- 2021-07-27
- 2022-01-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-13 | Pfizer-BioNTech | No |
Free text
Release 9 — day 0, dose 1
Systemic reaction (other): Minor pain at injection site, but at normal level I experience with any vaccine.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Reaction to previous exposure to any vaccine | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release